{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:08:20Z","timestamp":1787875700022,"version":"build-2784847793"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Primary cutaneous follicle center lymphoma (PCFCL) is a type of cutaneous B-cell lymphoma with an indolent behavior and a 5-year disease-specific survival of 95%. Given the difficulty of identifying patients at risk for developing extracutaneous dissemination (ECD), this study aimed to identify predictors in the clinical presentation, histopathology, immune phenotype, and genetic profile of PCFCL patients by comparing those who developed ECD with those whose disease remained skin limited (SL) during follow-up. After review of clinical data and histopathology, a total of 13 ECD-PCFCL patients and 15 SL-PCFCL patients with varying treatments were included from the Dutch Cutaneous Lymphomas Registry. At diagnosis, all patients presented with classic PCFCL lesions on the trunk or head-and-neck region, and histology indicated a predominance of centrocytes admixed with centroblasts. IgM expression was significantly more frequent in ECD-PCFCL (54%) than in SL-PCFCL (7%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.006). Targeted next-generation sequencing (NGS) with a 200 B-cell lymphoma-related gene panel demonstrated known PCFCL-like mutations in both groups. In addition, ECD-PCFCL demonstrated an enrichment of mutations associated with the activated B-cell genotype, including <jats:italic toggle=\"yes\">MYD88<\/jats:italic> (n=2), and some unique mutations, such as in ERBB4 (n=4). In conclusion, this study identified IgM expression at diagnosis as a potential biomarker for extracutaneous spread in PCFCL. In IgM-positive cases, genetic testing may be warranted. Patients with uncommon mutational profiles, such as those resembling the ABC-DLBCL genotype, may particularly benefit from closer follow-up and consideration of more aggressive treatment, including immuno-polychemotherapy. As these observations were made in a limited number of patients, our results require validation in an independent cohort.<\/jats:p>","DOI":"10.1097\/pas.0000000000002436","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:00:16Z","timestamp":1749805216000},"page":"931-941","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center Lymphoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Anne M.R.","family":"Schrader","sequence":"first","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben A.L.","family":"de Groen","sequence":"additional","affiliation":[{"name":"Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rein","family":"Willemze","sequence":"additional","affiliation":[{"name":"Dermatology, Leiden University Medical Center, Leiden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty M.","family":"Jansen","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen D.","family":"Quint","sequence":"additional","affiliation":[{"name":"Dermatology, Leiden University Medical Center, Leiden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van Wezel","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"van Eijk","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ruano","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis P.","family":"Tensen","sequence":"additional","affiliation":[{"name":"Dermatology, Leiden University Medical Center, Leiden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Diepstra","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Groningen, Groningen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Groningen, Groningen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"Koens","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kakiailatu","sequence":"additional","affiliation":[{"name":"Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten H.","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Dermatology, Leiden University Medical Center, Leiden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost S.P.","family":"Vermaat","sequence":"additional","affiliation":[{"name":"Hematology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"R1-20250815","first-page":"1112","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"134","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"R2-20250815","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":"IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R3-20250815","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"R4-20250815","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum Pathol"},{"key":"R5-20250815","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"key":"R6-20250815","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-018-2384-3","article-title":"Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein","volume":"473","author":"Gango","year":"2018","journal-title":"Virchows Arch"},{"key":"R7-20250815","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 Somatic mutation is a diagnostic criterion in primary cutaneous large B-cell lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R8-20250815","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R9-20250815","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/his.13279","article-title":"Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas","volume":"71","author":"Verdanet","year":"2017","journal-title":"Histopathology"},{"key":"R10-20250815","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2014.01.862","article-title":"Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis","volume":"70","author":"Abdul-Wahab","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R11-20250815","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","article-title":"Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas","volume":"123","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R12-20250815","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41379-018-0041-7","article-title":"Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas","volume":"31","author":"Menguy","year":"2018","journal-title":"Mod Pathol"},{"key":"R13-20250815","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/PAS.0000000000001132","article-title":"High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Schrader","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R14-20250815","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/DAD.0000000000000738","article-title":"An aggressive primary cutaneous follicle center lymphoma with c-MYC translocation and CDKN2A (9p21) deletion: a case report and review of the literature","volume":"39","author":"Tsang","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"R15-20250815","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"R16-20250815","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.jid.2017.06.016","article-title":"Spindle-cell variants of primary cutaneous follicle center B-cell lymphomas are germinal center B-cell lymphomas by gene expression profiling using a formalin-fixed paraffin-embedded specimen","volume":"137","author":"Oschlies","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R17-20250815","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch Dermatol"},{"key":"R18-20250815","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fonc.2020.00651","article-title":"Primary cutaneous B-cell lymphomas: an update","volume":"10","author":"Vitiello","year":"2020","journal-title":"Front Oncol"},{"key":"R19-20250815","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yexmp.2012.06.004","article-title":"Assessment of a fully automated high-throughput DNA extraction method from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis","volume":"94","author":"van Eijk","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"R20-20250815","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"key":"R21-20250815","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-021-03265-5","article-title":"Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas","volume":"480","author":"Schrader","year":"2022","journal-title":"Virchows Arch"},{"key":"R22-20250815","first-page":"3760","article-title":"Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype","volume":"5","author":"de Groen","year":"2021","journal-title":"Blood Adv"},{"key":"R23-20250815","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/HS9.0000000000000169","article-title":"The need for a consensus next-generation sequencing panel for mature lymphoid malignancies","volume":"3","author":"Sujobert","year":"2019","journal-title":"Hemasphere"},{"key":"R24-20250815","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jtho.2020.01.019","article-title":"Optimizing mutation and fusion detection in NSCLC by sequential DNA and RNA sequencing","volume":"15","author":"Cohen","year":"2020","journal-title":"J Thorac Oncol"},{"key":"R25-20250815","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ng.2854","article-title":"Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database","volume":"46","author":"Thompson","year":"2014","journal-title":"Nat Genet"},{"key":"R26-20250815","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B-cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"R27-20250815","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B-cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"R28-20250815","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"R29-20250815","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/his.13832","article-title":"Primary cutaneous large B-cell lymphomas: relevance of the 2017 WHO classification","volume":"74","author":"Menguy","year":"2019","journal-title":"Histopathology"},{"key":"R30-20250815","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jvc2.186","article-title":"Primary cutaneous follicle centre lymphoma with secondary systemic evolution","volume":"2","author":"Li","year":"2023","journal-title":"JEADV Clinical Practice"},{"key":"R31-20250815","doi-asserted-by":"crossref","first-page":"100465","DOI":"10.1016\/j.modpat.2024.100465","article-title":"Profiling of copy number alterations using low-coverage whole-genome sequencing informs differential diagnosis and prognosis in primary cutaneous follicle center lymphoma","volume":"37","author":"Batai","year":"2024","journal-title":"Mod Pathol"},{"key":"R32-20250815","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/leu.2010.302","article-title":"The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma","volume":"25","author":"Ruminy","year":"2011","journal-title":"Leukemia"},{"key":"R33-20250815","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13402-020-00499-4","article-title":"The role of ErbB4 in cancer","volume":"43","author":"Segers","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"R34-20250815","doi-asserted-by":"crossref","first-page":"14783","DOI":"10.1002\/jcp.28277","article-title":"The crucial role of ZEB2: from development to epithelial-to-mesenchymal transition and cancer complexity","volume":"234","author":"Fardi","year":"2019","journal-title":"J Cell Physiol"},{"key":"R35-20250815","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/ijms17050683","article-title":"Gene mutation profiles in primary diffuse large B Cell lymphoma of central nervous system: next generation sequencing analyses","volume":"17","author":"Todorovic Balint","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R36-20250815","first-page":"481","article-title":"Genetic and functional drivers of diffuse large B-cell","volume":"171","author":"Reddy","year":"2017","journal-title":"Lymphoma Cell"},{"key":"R37-20250815","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.3390\/cancers14205152","article-title":"Genetic stability of driver alterations in primary cutaneous diffuse large B-cell lymphoma, leg type and their relapses: a rationale for the use of molecular-based methods for more effective disease monitoring","volume":"14","author":"Schrader","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R38-20250815","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","article-title":"False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms","volume":"104","author":"King","year":"2019","journal-title":"Haematologica"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T04:00:27Z","timestamp":1755230427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002436","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]}}}